ALB and COVID-19: Consistent with the emerging COVID-19 literature, we observed an association between laboratory markers of acute phase inflammatory response (elevated neutrophil count, CRP, depressed lymphocytes and albumin), cardiac injury, activation of thrombosis and renal impairment with subsequent adverse outcome.6 21 26 We found a combination of CRP, albumin, urea, neutrophil:lymphocyte ratio and creatinine alongside simple demographics achieved an AUC of 0.79 (95% CI 0.67 to 0.91) when predicting 28-day mortality and 0.70 (95% CI 0.56 to 0.84) for the composite endpoint.